A session with a therapist can be a starting point for discussing potential benefits or concerns related to taking medication, although in most cases, prescriptions are issued by medical ...

Moderna Inc. said Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed higher ...

The vaccine will be Moderna’s second product to enter the U.S. market after the FDA’s approval of the biotech company’s COVID ...

On behalf of our nursing faculty and staff, welcome to the Wilkes University Passan School of Nursing! With a more than 40-year history of educating nurses, the Passan School of Nursing offers an ...

At UNG, you will have the opportunity to draw upon some of the most creative, qualified, and professional faculty in nursing and other related disciplines. In harmony with the university’s mission, ...

Moderna developed the Spikevax COVID-19 vaccine, and regulators approved this year its vaccine for RSV or respiratory syncytial virus. The company also has a combination flu/COVID vaccine and an ...

A master’s in nursing can help you qualify for jobs as a nurse practitioner, nurse anesthetist, nurse specialist or nurse midwife. In addition to advanced medical knowledge, nurses with a master ...

Saint Louis University’s Trudy Busch Valentine School of Nursing prepares students for professional nursing practice at baccalaureate, master's, post-master's and doctoral levels. You will also learn ...

Moderna's Spikevax KP.2 targets the KP.2 variant of the virus. The U.S. Food and Drug Administration has also approved the shot, as well as updated vaccines from Pfizer and BioNTech. Moderna (MRNA ...

Explore the best nursing programs online for various specialties and get a feel for the curriculum and topics covered in each. See how nursing programs online rank in various concentrations and ...

Novavax's traditional protein-based shot offers an alternative vaccine technology to those that are based on messenger RNA - Moderna's Spikevax and Comirnaty, which is jointly developed by Pfizer ...

Until now, Canada has only had access to vaccine formulas that were approved in fall 2023 and target the Omicron XBB.1.5. Moderna's latest formulation of their mRNA vaccine, Spikevax, targets the KP.2 ...